SCbio partnering with MassBio on a new accelerator
The biannual program named SCbioDrive will select up to six seed stage therapeutic and medical device companies for the eight-week course.
SCbio, in partnership with MassBio, has announced a new accelerator program designed to advance emerging companies through expert business curricula, industry guidance, and mentorship.
The biannual program named SCbioDrive will select up to six seed stage therapeutic and medical device companies for an eight-week course, which will consist of seven weeks of virtual instruction followed by one week in person at SCbio facilities in Charleston, SC. Company founders will complete industry-specific curriculum modules, led by experts from leading companies within the Palmetto State, which will include:
- Business Planning and Commercialization;
- Fundraising;
- People Strategy and Operations;
- Drug Discovery and Therapeutics;
- Intellectual Property and Legal;
- Regulatory Strategy; and
- Business Scaling.
The program will conclude with an in-person demo day.
“SCbioDrive will give emerging life science companies a solid foundation of resources, increased access to capital and continued mentorship from a network of established business leaders,” said James Chappell, SCbio President and Chief Executive Officer. “We want this program to show entrepreneurs that South Carolina is the state where businesses, at their earliest stages, are set up for success and sustained growth.”
SCbioDrive will launch this fall. Applications for the inaugural program cohort will be available in June.
Like what you've read?
Forward to a friend!